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Traumatic brain injury (TBI) is a debilitating injury that
affects numerous individuals, as it may result from trauma
sustained by motor vehicle accidents, sports injuries, combat, or other events. The long-term effects of TBI are debilitating and pervasive and can impact an individual’s family,
career, and overall ability to function in society. This special
issue of Cell Transplantation is dedicated to providing new
information related to biological therapies for TBI and factors contributing to disability, including discussions about
inflammation, the elucidation of new molecular targets,
alterations in gene expression, cell therapy, neurogenesis,
and therapeutic molecules. This special issue underscores
the need for more investigation of TBI and presents a wide
array of research currently being conducted.
Galgano et al. open the issue by providing background
information and reviewing the current clinical treatment
modalities for TBI, including surgical interventions and
postinjury seizure prophylaxis. Mild TBI is discussed in a
second review by Fehily et al., and the final review discusses
how changes in dopamine levels may exacerbate the pathogenesis and pathophysiology of TBI.
In a study of military personnel with TBI, Devoto et al.
discuss the role of inflammation in long-term behavioral and
neurological deficits resulting from the injury. The researchers found a relationship between chronic inflammation and
brain dysfunction and a relationship between the comorbidity of TBI and post-traumatic stress disorder (PTSD) and
inflammation.
Other studies in the issue focused on beneficial molecules
in TBI therapy. Merkel et al. found that dexamethasone may
be a viable option for curbing TBI-associated cocaine dependence, as individuals with TBI are often susceptible to substance abuse. Withania somnifera, a root extract commonly
used in traditional medicine, was evaluated as a potential
neuroprotective agent for TBI by Saykally et al. Lastly, Allitt
et al. found that progesterone helped improve the response
profile (neuronal firing) in the cortex of a rat model of TBI.
Transplantation studies using extracellular matrix (ECM)
and cells are also included in the current issue. Wu et al. used
ECM derived from porcine (pig) brains to transplant

TBI-modeled mice and found that neurobehavioral function
was improved and lesion volume was reduced. Focused
ultrasound and magnetic targeting of human neural progenitor cells in rats was explored by Shen et al., who showed that
migration of therapeutic cells to the brain was improved.
Beretta et al. also transplanted therapeutic cells for a murine
model of TBI. Using human neural stem cells (hNSCs), the
researchers showed that performance on hippocampal-based
memory tasks was improved. Likewise, Wang et al. transplanted a rat model of TBI with mouse-derived neural stem
cells (NSCs), which resulted in decreased apoptosis and
improved neurological function, as evidenced by neurological severity scores (NSS). The findings in these studies raise
the question of whether various pathological features and
functional deficits that result from TBI could be improved
using a cell-based therapeutic.
Wang et al. further evaluated apoptosis in TBI by testing
whether suppression of a member of the tripartite motif
(TRIM) protein family, Trim32, could inhibit apoptosis
post-TBI. Using TBI rats, the group showed that Trim32
downregulation facilitated recovery of neurological function, as determined by NSS and that suppression of apoptosis
was likely the mechanism by which this improvement was
achieved. Alteration of protein and gene expression is
another topic in this special issue that was next explored
by Baek et al., who sought to uncover how gene expression
patterns changed in the brain following spinal cord injury
(SCI). SCI is another debilitating and trauma-based injury
that has an effect on the brain. The group identified several
pathways that were altered postinjury and concluded that
1

Department of Neurosurgery and Brain Repair, Center of Excellence for
Aging and Brain Repair, Morsani College of Medicine, University of South
Florida, Tampa, FL, USA

Corresponding Author:
Paul R. Sanberg, Department of Neurosurgery and Brain Repair, Center of
Excellence for Aging and Brain Repair, Morsani College of Medicine,
University of South Florida, 12901 Bruce B. Downs Blvd, MDC 78,
Tampa, FL 33612, USA.
Email: psanberg@gmail.com

Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License
(http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Portis and Sanberg

gene expression plays a significant role in the pathophysiology of central nervous system injuries. Shojo et al. used a
fluid percussion TBI model to examine the role of two
inflammatory signaling molecules, prostaglandin and
cyclooxygenase 1, in TBI-related neuroinflammation. The
results underscore a need to identify therapeutic targets in
future research endeavors.
Also employing the fluid percussion injury model,
Shapiro sought to show how hippocampal neurogenesis is
altered following TBI. In a brief report, the researcher
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showed that neurogenesis was significantly decreased at
later time points postinjury and postulated that changes in
levels of cytokines, chemokines, and growth factors produce
an inhospitable environment, thus resulting in stymied
neurogenesis.
There is currently a need for more clinical trials for TBI,
and there exists a lack of trials that use regenerative medicine techniques. This special issue introduces a myriad of
possible therapeutic agents and/or methods and underscores
the need for further investigation for this condition.

